FELIX BAKER
CIK 1087940 · last filed 2026-06-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.48B
Companies
30
Total Filings
290
Lifetime Open-Market Net
$2.79B
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| INCY | Director | 3,115,871 | $108.53 | $338.17M | -$15.68M | 30 | 2026-06-10 |
| KNSA | Director | 2,759,734 | $51.89 | $143.20M | $324.00M | 4 | 2026-06-02 |
| VTVT | Director | 12,368 | $32.77 | $405.2K | $0 | 2 | 2025-09-05 |
| MDGL | Director | 1,796,261 | $480.77 | $863.59M | $0 | 2 | 2025-06-24 |
| DBVT | Director | — | $17.41 | — | $0 | 1 | 2025-03-31 |
| ONC | Director | 730,643 | $264.48 | $193.24M | -$1.14B | 1 | 2025-02-28 |
| IGM Biosciences, Inc. (IGMS) Delisted | Director | 3,123,770 | $1.27 | $3.97M | $20.59M | 2 | 2024-03-14 |
| Neurogene Inc. (NLTX) Delisted | Director | 156,326 | $13.96 | $2.18M | $38.80M | 3 | 2023-10-10 |
| TRDA | 10%+ Owner | 360,122 | $6.46 | $2.33M | $2.77M | 2 | 2022-06-06 |
| KOD | Director | 14,393,675 | $34.06 | $490.25M | $436.10M | 5 | 2022-02-17 |
| Talis Biomedical Corp (TLIS) Delisted | Director | 7,053,176 | $2.84 | $20.03M | $1.31M | 1 | 2021-11-19 |
| Seagen Inc. (SGEN) Delisted | Director | 4,124,966 | $228.74 | $943.54M | $2.56B | 33 | 2021-05-18 |
| BeOne Medicines Ltd. (BGNE) Delisted | Director | 18,590 | $184.71 | $3.43M | -$160.29M | 1 | 2021-01-06 |
| PRLD | Director | 9,247,763 | $4.49 | $41.52M | $180.00M | 1 | 2020-09-30 |
| Atreca, Inc. (BCEL) Delisted | 10%+ Owner | — | $0.15 | — | $0 | 1 | 2020-07-20 |
| Neurogene Inc. (AQXP) Delisted | Director | 1,178,742 | — | — | $6.69M | 1 | 2019-08-08 |
| Aceragen, Inc. (IDRA) Delisted | Director | 89,233 | $7.22 | $644.7K | -$20.91M | 14 | 2019-04-03 |
| GENOMIC HEALTH INC (GHDX) Delisted | Director | 185,836 | — | — | -$232.16M | 49 | 2019-03-19 |
| Mirati Therapeutics, Inc. (MRTX) Delisted | 10%+ Owner | 3,054,192 | $58.70 | $179.28M | $0 | 1 | 2016-04-01 |
| BCRX | 10%+ Owner | 2,145,586 | $8.70 | $18.67M | $7.12M | 7 | 2016-02-09 |
| SYNAGEVA BIOPHARMA CORP (GEVA) Delisted | Director | 50,111 | — | — | $270.67M | 14 | 2015-06-22 |
| ACAD | Director | 1,468,014 | $21.09 | $30.96M | $201.38M | 3 | 2013-06-11 |
| Ardea Biosciences, Inc./DE (RDEA) Delisted | Director | 116,454 | — | — | $93.93M | 18 | 2012-02-03 |
| VIROPHARMA INC (VPHM) Delisted | 10%+ Owner | 9,840,469 | — | — | $219.64M | 22 | 2011-12-16 |
| AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted | 10%+ Owner | 72,731 | — | — | -$7.68M | 5 | 2011-08-03 |
| RPRX | 10%+ Owner | 6,432,782 | $54.87 | $352.97M | $4.61M | 2 | 2010-06-02 |
| ALLOS THERAPEUTICS INC (ALTH) Delisted | 10%+ Owner | 83,205 | — | — | $14.68M | 15 | 2009-02-06 |
| NEUROGEN CORP (NRGN) Delisted | Director | 690,856 | — | — | $0 | 12 | 2008-11-13 |
| TAPESTRY PHARMACEUTICALS, INC (TPPH) Delisted | 10%+ Owner | 41,120 | — | — | -$173 | 1 | 2008-04-08 |
| Aceragen, Inc. (IDP) Delisted | 10%+ Owner | 502,680 | — | — | -$7.15M | 10 | 2007-12-07 |
Recent Filings · Page 4 of 29
290 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-08-08 | Neurogene Inc. (AQXP) Delisted | Buy (P) | +2,229,150 | $6.69M | EDGAR |
| 2019-06-07 | KNSA | Other (J) | −1,024,458 | $0 | EDGAR |
| 2019-06-05 | KOD | Grant (A) | — | $0 | EDGAR |
| 2019-04-03 | Aceragen, Inc. (IDRA) Delisted | Grant (A) | +87,381 | $226.3K | EDGAR |
| 2019-03-19 | GENOMIC HEALTH INC (GHDX) Delisted | Sell (S) | −2,700,060 | -$201.03M | EDGAR |
| 2018-11-13 | GENOMIC HEALTH INC (GHDX) Delisted | Sell (S) | −2,043,000 | -$162.07M | EDGAR |
| 2018-11-13 | GENOMIC HEALTH INC (GHDX) Delisted | Sell (S) | −762,730 | -$65.98M | EDGAR |
| 2018-07-03 | GENOMIC HEALTH INC (GHDX) Delisted | Grant (A) | +23,760 | $1.20M | EDGAR |
| 2018-05-31 | KNSA | Mixed | +18,000,000 | $324.00M | EDGAR |
| 2018-05-08 | Seagen Inc. (SGEN) Delisted | Buy (P) | +2,763,906 | $147.42M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.